Table 3. Evaluation parameters of in-situ gelling formulations .
Formulation code | Gelation temperature before dilution ( o C )* | Gelation temperature after dilution ( o C )* | Gelling ability# | pH | Spreadability (cm)* | Viscosity (cp at 20 rpm) | Drug release after 8 h ( %)* |
F1 | 20.2±0.1 | 21.3±0.1 | ++ | 4.2 | 1.0±0.2 | 2021 | 46.07±0.5 |
F2 | 29.0±0.2 | 30.1±0.2 | +++ | 4.5 | 2.5±0.1 | 2116 | 46.18±0.3 |
F3 | 24.6±0.2 | 25.4±0.2 | +++ | 6.2 | 1.3±0.1 | 1416 | 38.57±0.2 |
F4 | 19.1±0.1 | 20.7±0.3 | ++ | 7.0 | 1.8±0.1 | 1596 | 46.53±0.5 |
F5 | 30.4±0.1 | 31.5±0.2 | +++ | 4.5 | 3.8±0.2 | 1095 | 21.95±1.0 |
F6 | 31.1±0.1 | 32.7±0.1 | +++ | 6.8 | 2.9±0.3 | 2020 | 34.99±0.2 |
F7 | 27.9±0.2 | 28.4±0.2 | +++ | 5.9 | 2.0±0.2 | 2165 | 42.91±0.1 |
F8 | 31.7±0.1 | 32.4±0.2 | +++ | 6.2 | 3.2±0.1 | 1995 | 38.14±0.2 |
F9 | 28.2±0.2 | 29.6±0.2 | +++ | 4.5 | 2.6±0.2 | 1982 | 45.37±0.5 |
F10 | 20.6±0.2 | 21.8±0.2 | +++ | 7.0 | 1.6±0.2 | 2591 | 43.85±0.2 |
F11 | 32.3±0.2 | 33.8±0.2 | ++ | 6.0 | 4.5±0.1 | 2065 | 30.72±0.3 |
F12 | 33.3±0.2 | 34.8±0.2 | +++ | 5.2 | 4.8±0.2 | 1985 | 27.99±0.1 |
F13 | 26.7±0.2 | 27.2±0.2 | +++ | 6.5 | 2.2±0.2 | 5623 | 38.57±0.5 |
F14 | 34.5±0.2 | 35.8 ±0.2 | +++ | 5.6 | 5.3±0.05 | 2135 | 28.18±0.2 |
F15 | 32.0±0.2 | 33.2±0.2 | +++ | 6.3 | 5.5±0.1 | 4659 | 42.46±0.3 |
F16 | 29.0±0.2 | 30.2±0.2 | +++ | 5.3 | 3.3±0.2 | 3592 | 46.18±0.5 |
F17 | 28.2±0.2 | 29.7±0.2 | +++ | 5.5 | 3.5±0.2 | 3165 | 45.37±0.1 |
*Mean ±SD (n=3) #Gelling ability: No phase transition (-), gel formation after 60s and collapsed rapidly within 1 h (+), gel formation after 60s and gel collapsed within 3 h (++) and gel formation within 60s and stable for more than 6 h (+++).